Navigation Links
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Date:1/18/2008

Fifth Disease Indication for HUMIRA Provides Patients with Visible Clearance of Inflamed Skin Lesions Caused by Chronic Autoimmune Disease

ABBOTT PARK, Ill., Jan. 18 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA(R) (adalimumab) as a treatment for adult patients with moderate to severe chronic plaque psoriasis, an autoimmune disease characterized by skin lesions that are sometimes painful and itchy. HUMIRA has been approved for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HUMIRA should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician.

The approval is based on two pivotal trials, REVEAL and CHAMPION, showing that nearly 3 in 4 patients achieved 75 percent clearance or better at week 16 of treatment versus placebo. HUMIRA has 10 years of clinical trial experience beginning with rheumatoid arthritis patients. It was approved for moderate to severe rheumatoid arthritis in 2002, psoriatic arthritis in 2005, ankylosing spondylitis in 2006, and moderate to severe Crohn's disease in 2007.

"The approval of HUMIRA for psoriasis is welcome news for people living with this challenging, lifelong disease," said Pam Field, acting president and CEO, National Psoriasis Foundation. "We are pleased to let people with plaque psoriasis know they now have a new treatment option available to them."

Psoriasis affects an estimated 125 million people worldwide, with approximately 25 percent of patients experiencing moder
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., BETHESDA,Md.,Nov.24/PRNewswire-Asia/--Chind...eadingindependentAmericanproviderofWestern,healthc...,today,announcedthattheCompanywillattendthe21stAnn...beheldDecember1-2,2009,atthe,NewYorkPalaceHotel. ,...30amETonTuesday,December1,2009,andholdone-on-onem...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:...yearsfollowinganautoaccident,wasactuallyfullyconsc...orningAmericasegment.TheDynaVoxEyeMaxwasfeaturedin...meandotherconditionscanunlockcommunication. ,, ...ableonlineat www.dynavoxtech.com ,, WHO:...
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Female human embryos adjust the balance of X chromosomes before implantation 9041 1Female human embryos adjust the balance of X chromosomes before implantation 9041 2Female human embryos adjust the balance of X chromosomes before implantation 9041 3Female human embryos adjust the balance of X chromosomes before implantation 9041 4Sevocity Launches EHR 28Electronic Health Record 29 Interface With Austin Radiological Association 50278 1Sevocity Launches EHR 28Electronic Health Record 29 Interface With Austin Radiological Association 50278 2Sevocity Launches EHR 28Electronic Health Record 29 Interface With Austin Radiological Association 50278 3BioStorage Technologies Inc Appoints Jeff Goddard to Global Head of Sales 12825 1BioStorage Technologies Inc Appoints Jeff Goddard to Global Head of Sales 12825 2
...uvant for Vaccines,against Avian Flu and Other Vir...FirstCall/ -- IR,BioSciences Holdings, Inc. announ... vaccine adjuvant study being performed in,conjunc... host,immune responsiveness above that induced by ...going study, and are a strong,indication that Homs...
...FirstCall/ --,Citing issues related to potentially...or Medsystems, LLC has concluded that the COSTAR,I...r Restenosis),trial, the pivotal study for the CoS...ent, failed to meet its primary,endpoint. The tria...rates of death, myocardial infarction and stent th...
Other Medicine Technology:IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 2IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 3IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 4Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 2Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 3Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 4
(Date:11/24/2009)...swire-USNewswire/--OnFriday,November20,juniorfeath...lblowtotheheadduringatitleboutinPhiladelphia.Hewas...hislifewereconducted,hewasdeclaredbraindeadonSunda...procurementorganization(OPO)servingeasternPennsylv...hehospitalaspartofstandardclinicalprocedurestodete...
(Date:11/24/2009)...RNewswire-USNewswire/--Parties,familydinners,andot...aycheer.Butthemerrimentcanchangetomiseryiffoodmake...om/cgi-bin/prnh/20090824/FDALOGO ) ,, Typicalsy...u-likesymptoms,whichcanstartanywherefromhourstoday...Thegoodnewsisthatpracticingfourbasicfoodsafetymeas...
(Date:11/24/2009)...RNewswire-USNewswire/--IPROhasachieveditsthirdcons...gementstandardfocusedonfulfillingcustomerrequireme...rovingbusinessperformance.CertificationtoISO9001:2...O,sQualityManagementSystem(QMS)haspassedarigorouse...keSuccessandAlbany,NewYorkaswellasatitsaffiliateLo...
(Date:11/24/2009)...RNewswire/--Mostpeoplelookforwardtokickingofftheho...ithfriendsandfamily.TheMacombCountyHealthDepartmen...idays.Travelingandbeinginlargegroupsareeasywaystos...hy: ,, VACCINATION ,, Thefirstandmostimpor...ccinatedagainsttheH1N1strainoftheflu.TheMacombCoun...
(Date:11/24/2009)...24/PRNewswire/--Nextmonth,UnitedHealthcarewilloffe...panic-AmericanseniorsunderstandthebasicsofMedicare...eeZumba®Goldclass,aLatin-infusedfitnessprogra...,andtango. ,, UnitedHealthcarewillofferthesesem...gedwhenlearningabouttheirhealthcareoptions. There...
Breaking Medicine News(10 mins):Health News:Paying Tribute to Boxer Francisco 'Paco' Rodriguez 2Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2
...are ready to make major changes in their lives and...ations when faced with serious outbreak of pandemi...onducted by the Harvard School of Public Health (H...e for them if they become ill or would face seriou...
...ine used to treat cardiovascular diseases in China...onjunction// with traditional treatments, accordin...ies included in the review, taking tongxinluo impr...ac patients with angina. “Tongxinluo is one ...
...ished online this week in The Lancet warns that tu... a threat from tuberculosis strains //that are res... The study conducted by a team of researchers ... widespread in a rural area of KwaZulu Natal, Sout...
...diabetes in middle age could face more complicatio...ge, reveals a new study.// Elizabeth Selvin o...lth and other researchers looked at more than 2,80... The survey showed that more than 15 percent...
... shirk his responsibilities, Health Minister Anbum...the spread of dengue//, which has so far taken tol... interview with Karan Thapar for the CNN-IBN progr...nts who have to take steps." According to th...
... Eating Disorders, an international organization f...on professionals//, calls for a global ban on the ...s and in fashion magazines, and encourages the ind...recedented move of a major fashion show in Spain t...
Other Medicine News:Health News:Fears of Pandemic Flu makes Americans Ready for Change 2Health News:Fears of Pandemic Flu makes Americans Ready for Change 3Health News:Fears of Pandemic Flu makes Americans Ready for Change 4Health News:Fears of Pandemic Flu makes Americans Ready for Change 5Health News:Fears of Pandemic Flu makes Americans Ready for Change 6Health News:Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients 2Health News:Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients 3Health News:Threat posed by highly resistant strains of TB 2Health News:Ramadoss Blames State Governments for High Dengue Toll 2Health News:Ramadoss Blames State Governments for High Dengue Toll 3Health News:Academy for Eating Disorders Calls for Ban on Underweight Models 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: